Evoke Pharma, Inc. (Nasdaq: EVOK) announced the initiation of its Phase 3 clinical trial investigating the use of EVK-001, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE